Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Neogenomics Inc (NEO)

Neogenomics Inc (NEO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,447,056
  • Shares Outstanding, K 110,431
  • Annual Sales, $ 408,830 K
  • Annual Income, $ 8,010 K
  • 60-Month Beta 0.82
  • Price/Sales 10.79
  • Price/Cash Flow 77.18
  • Price/Book 6.75

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate 0.03
  • Number of Estimates 3
  • High Estimate 0.05
  • Low Estimate 0.00
  • Prior Year 0.04
  • Growth Rate Est. (year over year) -25.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
35.00 +11.23%
on 07/28/20
41.03 -5.12%
on 08/07/20
+3.62 (+10.25%)
since 07/14/20
3-Month
25.19 +54.55%
on 06/01/20
41.03 -5.12%
on 08/07/20
+11.17 (+40.24%)
since 05/14/20
52-Week
18.52 +110.21%
on 10/02/19
41.03 -5.12%
on 08/07/20
+14.36 (+58.45%)
since 08/14/19

Most Recent Stories

More News
Neogenomics Inc Has Returned 29.7% Since SmarTrend Recommendation (NEO)

SmarTrend identified an Uptrend for Neogenomics Inc (NASDAQ:NEO) on June 30th, 2020 at $30.19. In approximately 1 month, Neogenomics Inc has returned 29.68% as of today's recent price of $39.15.

NEO : 38.93 (-3.33%)
Innovative Technological Advancements Improve Early Cancer Diagnoses

, /PRNewswire/ --  Cancer biomarkers have gained significant importance in the drug-development process in recent years. In particular, microarray technologies provide analysis of tens of thousands of...

NEO : 38.93 (-3.33%)
SGEN : 157.27 (-1.79%)
BMY : 63.16 (-0.13%)
MRK : 83.48 (-0.07%)
Innovative Technological Advancements Improve Early Cancer Diagnoses

- FinancialBuzz.com News Commentary

BMY : 63.16 (-0.13%)
MRK : 83.48 (-0.07%)
NEO : 38.93 (-3.33%)
SGEN : 157.27 (-1.79%)
Expected Growth in Cancer Cases Reinforces Need for Superior Diagnostic Options

, /PRNewswire/ --The cancer diagnostics market is highly competitive, with a large number of big and small players operating in various market segments. Technological advancements in various fields such...

ANPC : 7.24 (+2.70%)
EXAS : 85.33 (-2.14%)
NEO : 38.93 (-3.33%)
VCYT : 33.79 (-2.96%)
MYGN : 12.66 (-5.38%)
Stocks Slide as Tech Stalls Again

Stocks Slide as Tech Stalls Again

BGS : 29.17 (-0.38%)
NTGR : 32.61 (-0.76%)
TPB : 28.80 (-1.81%)
CSPR : 8.17 (-6.09%)
STKL : 6.78 (+1.35%)
LVS : 48.37 (-0.51%)
INCY : 94.87 (-0.72%)
ADSW : 30.20 (unch)
NEO : 38.93 (-3.33%)
MIME : 45.09 (-1.75%)
MPC : 38.35 (+2.93%)
NVCR : 75.69 (-0.58%)
MTCH : 118.80 (+1.16%)
RUN : 45.63 (-2.35%)
TJX : 57.87 (+1.33%)
TIF : 125.00 (+0.16%)
VFC : 64.24 (+0.64%)
XYL : 79.62 (+0.18%)
YNDX : 60.04 (+0.93%)
GOOG : 1,507.73 (-0.71%)
AMZN : 3,148.02 (-0.41%)
AAPL : 459.63 (-0.09%)
PFE : 38.06 (-0.29%)
MMM : 166.10 (+0.14%)
MCD : 207.03 (+0.26%)
AMD : 81.30 (-0.66%)
NeoGenomics (NEO) Reports Q2 Loss, Tops Revenue Estimates

NeoGenomics (NEO) delivered earnings and revenue surprises of 55.56% and 1.01%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

NEO : 38.93 (-3.33%)
NeoGenomics Reports Revenue of $87 Million in the Second Quarter amid COVID-19 Pandemic

Clinical tests exclude requisitions, tests, revenue and costs for Pharma Services and COVID-19 Polymerase Chain Reaction ("PCR") tests.

NEO : 38.93 (-3.33%)
Neogenomics Inc Shares Up 22.0% Since SmarTrend's Buy Recommendation (NEO)

SmarTrend identified an Uptrend for Neogenomics Inc (NASDAQ:NEO) on June 30th, 2020 at $30.19. In approximately 3 weeks, Neogenomics Inc has returned 21.96% as of today's recent price of $36.82.

NEO : 38.93 (-3.33%)
Earnings Preview: NeoGenomics (NEO) Q2 Earnings Expected to Decline

NeoGenomics (NEO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

NEO : 38.93 (-3.33%)
NeoGenomics Announces Board Appointments

FT MYERS, FL / ACCESSWIRE / July 20, 2020 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services, announced today changes in the composition and certain roles of...

AGN : 193.02 (+0.02%)
MRK : 83.48 (-0.07%)
NEO : 38.93 (-3.33%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade NEO with:

Business Summary

NeoGenomics, Inc. is a high-complexity CLIA-certified clinical laboratory that specializes in cancer genetics diagnostic testing, the fastest growing segment of the laboratory industry. The company's testing services include cytogenetics, fluorescence in-situ hybridization, flow cytometry, morphology...

See More

Key Turning Points

2nd Resistance Point 40.86
1st Resistance Point 39.89
Last Price 38.93
1st Support Level 38.34
2nd Support Level 37.76

See More

52-Week High 41.03
Last Price 38.93
Fibonacci 61.8% 32.43
Fibonacci 50% 29.77
Fibonacci 38.2% 27.12
52-Week Low 18.52

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar